Article Details
Retrieved on: 2021-02-17 11:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Albright joins Affinia Therapeutics from Editas Medicine, where he served as executive vice president and chief scientific officer and led the development ...
Article found on: www.globenewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here